Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pinchas Cohen

Showing results (111-120 of 224) with videos related to

Pageof 23
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Combination therapy of insulin-like growth factor binding protein-3 and retinoid X receptor ligands synergize on prostate cancer cell apoptosis in vitro and in vivoBingrong Liu, Kuk-Wha Lee, Heju Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2008
Functionally significant insulin-like growth factor I receptor mutations in centenariansYousin Suh, Gil Atzmon, Mi-Ook Cho, et al.
Cancer Research|May 3, 2008
Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progressionMakoto Anzo, Laura J Cobb, David L Hwang, et al.
Aging Cell|July 22, 2014
IGF-I regulates the age-dependent signaling peptide humaninChanghan Lee, Junxiang Wan, Brian Miyazaki, et al.
Aging Cell|February 1, 2013
Protein restriction cycles reduce IGF-1 and phosphorylated Tau, and improve behavioral performance in an Alzheimer's disease mouse modelEdoardo Parrella, Tom Maxim, Francesca Maialetti, et al.
International Journal of Cancer|March 30, 2006
Insulin-like growth factor binding protein 3 as an anticancer molecule in Ewing's sarcomaStefania Benini, Monia Zuntini, Maria Cristina Manara, et al.
Physiological Reports|July 12, 2019
The mitochondrial-derived peptide MOTS-c is a regulator of plasma metabolites and enhances insulin sensitivitySu-Jeong Kim, Brendan Miller, Hemal H Mehta, et al.
Journal of the National Cancer Institute|September 12, 2018
Role of Host GPR120 in Mediating Dietary Omega-3 Fatty Acid Inhibition of Prostate CancerPei Liang, Susanne M Henning, Johnny Guan, et al.
The Journal of Clinical Endocrinology and Metabolism|March 17, 2005
p53-Dependent and p53-independent induction of insulin-like growth factor binding protein-3 by deoxyribonucleic acid damage and hypoxiaAdda Grimberg, Carrie M Coleman, Timothy F Burns, et al.
BMC Pregnancy and Childbirth|December 28, 2024
Development of a prognostic scoring system for predicting hospitalization duration in postpartum endometritisYael Yagur, Lisa Barcilon-Tiosano, Dana Segal, et al.
Pageof 23

Showing results (111-120 of 224) with videos related to

Sort By:
Pageof 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Combination therapy of insulin-like growth factor binding protein-3 and retinoid X receptor ligands synergize on prostate cancer cell apoptosis in vitro and in vivoBingrong Liu, Kuk-Wha Lee, Heju Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2008
Functionally significant insulin-like growth factor I receptor mutations in centenariansYousin Suh, Gil Atzmon, Mi-Ook Cho, et al.
Cancer Research|May 3, 2008
Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progressionMakoto Anzo, Laura J Cobb, David L Hwang, et al.
Aging Cell|July 22, 2014
IGF-I regulates the age-dependent signaling peptide humaninChanghan Lee, Junxiang Wan, Brian Miyazaki, et al.
Aging Cell|February 1, 2013
Protein restriction cycles reduce IGF-1 and phosphorylated Tau, and improve behavioral performance in an Alzheimer's disease mouse modelEdoardo Parrella, Tom Maxim, Francesca Maialetti, et al.
International Journal of Cancer|March 30, 2006
Insulin-like growth factor binding protein 3 as an anticancer molecule in Ewing's sarcomaStefania Benini, Monia Zuntini, Maria Cristina Manara, et al.
Physiological Reports|July 12, 2019
The mitochondrial-derived peptide MOTS-c is a regulator of plasma metabolites and enhances insulin sensitivitySu-Jeong Kim, Brendan Miller, Hemal H Mehta, et al.
Journal of the National Cancer Institute|September 12, 2018
Role of Host GPR120 in Mediating Dietary Omega-3 Fatty Acid Inhibition of Prostate CancerPei Liang, Susanne M Henning, Johnny Guan, et al.
The Journal of Clinical Endocrinology and Metabolism|March 17, 2005
p53-Dependent and p53-independent induction of insulin-like growth factor binding protein-3 by deoxyribonucleic acid damage and hypoxiaAdda Grimberg, Carrie M Coleman, Timothy F Burns, et al.
BMC Pregnancy and Childbirth|December 28, 2024
Development of a prognostic scoring system for predicting hospitalization duration in postpartum endometritisYael Yagur, Lisa Barcilon-Tiosano, Dana Segal, et al.
Pageof 23